Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells. 1998

I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
Department of Cancer Research, Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd., Shizuoka, Japan. ooizumiiwo@gt.chugai-pharm.co.jp

We have reported the isolation and specific in vitro properties of tumor-derived endothelial cells (TEC) from rat KMT-17 fibrosarcomas transplanted into rats. To develop antibody-based tumor vascular targeting therapy for solid tumors, we have generated monoclonal antibodies (MAbs) using passive immunization of outside-out membrane vesicles of rat epididymal-fat-pad-derived capillary endothelial cells (FCEC) followed by active immunization of those of rat TEC. The MAbs produced were screened against TEC and FCEC. Of all cultured hybridomas, 75 (3.3%) of the secreted MAbs preferentially recognized TEC. We selected a total of 7 MAbs which detected antigens highly abundant in TEC, although 5 of the 7 MAbs were weakly positive for FCEC in cell-ELISA and FACS analyses. The antigens recognized by these MAbs, with the exception of MAb TES-7, were present on endothelial cells of tumor blood vessels in KMT-17 fibrosarcoma tissues, as shown by immunohistochemical analysis. Antigens of 40- and 80-kDa were recognized by MAbs TES-1, 7, 17, 21 and 26 and by MAbs TES-23 and 27 respectively. Although the function of these antigens, which are preferentially expressed on rat tumor-derived endothelial cells, is still unknown, we believe that future studies of such antigens will help elucidate the role of endothelial cells in tumor vasculature. Our results indicate that MAbs may provide a novel tool for the development of antibody-based therapy targeting tumor vasculature.

UI MeSH Term Description Entries
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
April 1988, Transplantation,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
November 1998, Journal of comparative pathology,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
June 1998, Annals of the New York Academy of Sciences,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
January 1980, Contemporary topics in immunobiology,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
January 1983, Bulletin du cancer,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
May 1994, Annals of surgical oncology,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
January 1982, Springer seminars in immunopathology,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
January 1984, Critical reviews in immunology,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
June 2000, International journal of cancer,
I Ohizumi, and S Tsunoda, and K Taniguchi, and H Saito, and K Esaki, and K Koizumi, and H Makimoto, and Y Wakai, and J Matsui, and Y Tsutsumi, and S Nakagawa, and N Utoguchi, and Y Ohsugi, and T Mayumi
January 1984, Progress in clinical and biological research,
Copied contents to your clipboard!